April 19, 2018 / 5:04 AM / in 4 months

REFILE-BRIEF-Sofinnova Partners leads Inventiva Pharma's 35.3 mln euros capital increase

(Refiles to correct spelling of “Inventiva”)

April 19 (Reuters) - Sofinnova Partners/Inventiva Pharma:

* Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced today it has led Inventiva Pharma’s (IVA) €35,5 M capital increase through its newly created Sofinnova Crossover I Fund

* Sofinnova Partners invested €10 M, becoming one of the company’s largest investors

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below